Offstream
news

---

Changes

1. Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, where the trials will continue until March 2023.
   2021-11-16 21:06:14 (First version)
2. Russia authorizes Pfizer to conduct clinical trials for its experimental COVID-19 drug named Paxlovid, which will continue until March 2023.
   (Current version)

---

Related

Pfizer and the Medicines Patent Pool sign a global licensing agreement that will allow Pfizer's experimental COVID-19 oral drug Paxlovid to be manufactured under a royalty-free license in 95 low and middle-income countries.
2021-11-16

Russia reports a record 973 deaths from COVID-19 in the past 24 hours, thereby bringing the nationwide death toll to 218,345.
2021-10-12

Russia reports a record for the second consecutive day of 669 deaths from COVID-19, thereby bringing the nationwide death toll to 135,214.
2021-06-30

Venezuela reaches an agreement to buy doses of the Russian EpiVacCorona vaccine, as well as manufacture the vaccine locally.
2021-06-5

In a study published by the National Health Service, the Pfizer vaccine has been found to reduce hospitalizations in elderly people by 75%.
2021-04-14

Argentina receives their second batch of Russia's Sputnik V vaccine.
2021-01-16

Russia reports a new single-day record of 25,173 cases, bringing the nationwide total since the beginning of the pandemic to 2.11 million cases.
2020-11-23

Russia reports a record 442 new fatalities and 22,055 recoveries over the past 24 hours, bringing the nationwide death toll to 33,931 and nationwide recoveries to 1.47 million.
2020-11-17

Russia reports 12,846 cases, their highest since the start of the pandemic. The number of cases reaches to 1,285,084.
2020-10-10

The Brazilian state of Bahia is expected to conduct phase III trails of Russia's Gam-COVID-Vac vaccine and buy 50 million doses.
2020-09-11